MashupMD
@MdMashup
MashupMD is a medical platform that links specialists with the social media conversations going on in their fields. Follow for news in health care and medicine.
Target trial emulation is the new hotness in retrospective research. 🎧 In the latest Freely Filtered, @kidney_boy and Ed Fu break down metformin use below eGFR 30, depletion of susceptibles, SGLT2i in dialysis, and more. Learn more: mashupmd.com/expert-collect…
📺 In our recent video series, Drs. @VigneshPackiam of @RutgersCancer and @NitinYerram of @HUMCUrology explore the latest advances in #NMIBC, including combination #immunotherapy with BCG: buff.ly/Q3kTagh 👉 In the final part of the series, they conclude with the…
🔬 Predictive genomics is transforming breast cancer care by guiding treatment choices. Dr. Sadie Dobrozsi highlights how pharmacogenomics goes further to personalize dosing and reduce trial and error. Learn more: mashupmd.com/expert-collect…
🧬 The #KRAS gene is one of the most common oncogenic drivers in #GICancers Today, researchers have been expanding their efforts in targeting the gene and its mutations: buff.ly/zaXH1kB
🚨 PSMA PET imaging and radioligand therapy are gaining ground in prostate cancer. @GUOncologyNow spoke with experts on studies investigating the efficacy of these tools. 🔗 mashupmd.com/expert-collect…
💡 A $2.6M NIH grant backs a precision gene-editing project targeting HCM, the most common inherited heart condition. cardiocaretoday.com/post/2-6-milli… #GeneTherapy #HCM #CardioTwitter #Genetics
ICYMI: In a retrospective review presented at #ASCO25, patients with newly diagnosed #myeloma were considered to be at high risk for venous thromboembolism if they had a SAVED score of 2 or higher or an IMPEDE score of 4 or higher. 📰 buff.ly/0Y95VIR
⚙️ A new evaluation of several trials has shed light on the prognostic performance of the 15G score in patients with metastatic #ccRCC. 📉 Learn which treatments - including #sunitinib and #atezolizumab - were linked to worse PFS rates: guoncologynow.com/post/15-gene-p…
🥑This week, @drjkahn asks if ketogenic diets promote cancer and if plant-based diets prevent it. Also covered: diet quality and heart health, the President’s swollen ankles, homocysteine, AI and ECGs, and more. ➡️Continue reading: mashupmd.com/expert-collect…
📺Watch our new interview with @skopetz, where he explains how the BREAKWATER trial aligns with the FDA’s Project FrontRunner initiative by using early response rate data to support accelerated approval in BRAF V600E-mutated metastatic #colorectal cancer: gioncologynow.com/post/breakwate…
🫀New @CardioNerds episodes this month cover how HFpEF impacts metabolic, hormonal, and inflammatory factors in women’s health, multimodal imaging with Dr. Monica Mukherjee, and more Learn more: mashupmd.com/expert-collect…
💬 Dostarlimab plus chemo is comparable to placebo plus chemo for time to first quality of life improvement or deterioration in patients with advanced or recurrent endometrial cancer, according to a recent study presented at #ASCO25. ➡️ Read more: buff.ly/etqfrfK
☀️ Editors at @Lung_Cancers spotlight a new podcast and expert interviews on key lung cancer topics: family history, virtual palliative care, and more. 🌍 As #WCLC25 approaches, they’re also reflecting on last year’s practice-changing findings. mashupmd.com/expert-collect…
📝 A new analysis led by @DimaDanai, of @fredhutch, adds insight into the utility of teclistamab to treat relapsed or refractory multiple #myeloma in patients who have already undergone BCMA-directed therapy. ➡️ buff.ly/fTQ5DJ1
🎥New roundtable videos from @GiOncNow feature expert panelists discussing advances and ongoing research across multiple disease states. Drs. Uboha, Eng, Kopetz, & Janjigian review the MATTERHORN trial, aspirin in CRC, and more. 💡Stay updated: mashupmd.com/expert-collect…
💪This week, @drjkahn covers two studies on exercise, one showing a major drop in all-cause mortality and the other on the safety of endurance training. Learn about fisetin and atherosclerosis, ezetimibe plus statin for endothelial function, and more! ➡️ mashupmd.com/expert-collect…
💔 Women who feel lower on the social ladder show more heart scarring—even with similar income/education. Stress hits deep. Time to rethink heart disease risk. #CardioHealth #WomensHealth #SocialDeterminants cardiocaretoday.com/post/heart-ris…
🔎 A trial that compared the efficacy of #ramucirumab + #irinotecan against irinotecan monotherapy has found that both treatments provide a similar OS rate for patients with advanced #gastriccancer who experienced progression: buff.ly/qhHRDSc
🫁 The miracle of immune therapy continues to amaze. In MSS CRC, lung mets may respond even when others don’t. At #ESMOGI25, BOT/BAL showed a 20% response rate, 69% disease control, and 16.6 mo median response. 💡Learn more from @marshalj23: mashupmd.com/expert-collect…
📺 In our latest video series, Drs. @VigneshPackiam and @NitinYerram explore the latest advances in #NMIBC, including combination #immunotherapy with BCG: buff.ly/D11fEFh 👉 In part 1 of the series, they provide a foundational overview of NMIBC, highlighting how BCG has…